PITCHES trial protocol published in BioMedCentral Trials

With no existing evidence to support the use of ursodeoxycholic acid (UDCA) to improve intrahepatic cholestasis of pregnancy (ICP), PITCHES, a Phase III clinical trial proposes to provide definitive evidence to discover if the use of UDCA improves pregnancy outcomes in women with this liver disorder.

For more information, please find the recently published study protocol for the PITCHES trial in the BioMedCentral Trials journal here.

This study is funded by the National Institute for Health Research (NIHR) Efficacy and Mechanism Evaluation (EME) Programme (Reference Number 12/164/16). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.